Overexpression of C-type Natriuretic Peptide in Endothelial Cells Protects against Insulin Resistance and Inflammation during Diet-induced Obesity

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Bae, Cho Rong ^a   Hino, Jun ^a   Hosoda, Hiroshi ^a   Arai, Yuji ^a   Son, Cheol ^a   Makino, Hisashi ^a   Tokudome, Takeshi ^a   Tomita, Tsutomu ^a   Kimura, Toru ^a   Nojiri, Takashi ^a   Hosoda, Kiminori ^a   Miyazato, Mikiya ^a   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANYLATE CYCLASE; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C;

ADIPOCYTE; ANIMAL; ENDOTHELIUM CELL; ENERGY METABOLISM; GENE EXPRESSION; GENETICS; GLUCOSE INTOLERANCE; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIVER; METABOLISM; MOUSE; OBESITY; THERMOGENESIS; TRANSGENIC MOUSE;

ADIPOCYTES; ANIMALS; DIET, HIGH-FAT; ENDOTHELIAL CELLS; ENERGY METABOLISM; GENE EXPRESSION; GLUCOSE INTOLERANCE; GUANYLATE CYCLASE; INFLAMMATION; INSULIN RESISTANCE; LIVER; MICE; MICE, TRANSGENIC; NATRIURETIC PEPTIDE, C-TYPE; OBESITY; RNA, MESSENGER; THERMOGENESIS;

EID: 85028502602     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-10240-1     Document Type: Article

References (65)

1. Greenberg, A. S. et al. The role of lipid droplets in metabolic disease in rodents and humans. J. Clin. Invest. 121, 2102-2110 (2011).
2. Gimble, J. M. et al. Adipose-derived stromal/stem cells: a primer. Organogenesis. 9, 3-10 (2013).
3. Villaret, A. et al. Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic metabolic and inflammatory gene expression and cellular senescence. Diabetes. 59, 2755-2763 (2010).
4. Cao, Y. Angiogenesis and Vascular Functions in Modulation of Obesity, Adipose Metabolism, and Insulin Sensitivity. Cell. Metabolism. 18, 478-489 (2013).
5. Pellegrinelli, V., Rouault, C., Veyrie, N., Clement, K. & Lacasa, D. Endothelial cells from visceral adipose tissue disrupt adipocyte functions in a three dimensional setting: partial rescue by angiopoietin-1. Diabetes. 63, 535-549 (2014).
6. Brown, N. K. et al. Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. Arterioscler. Thromb. Vasc. Biol. 34, 1621-1630 (2014).
7. Levin, E., Gardner, D. & Samson, W. Natriuretic peptides. N. Engl. J. Med. 339, 321-328 (1998).
8. Mukoyama, M. et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J. Clin. Invest. 87, 1402-1412 (1991).
9. Komatus, Y. et al. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology. 129, 1104-1106 (1991).
10. Chen, H. H. & Burnett, J. C. Jr. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J. Cardiovasc. Pharmacol. 32, S22-S28 (1998).
11. Sudoh, T., Minamino, N., Kangawa, K. & Matsuo, H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168, 863-870 (1990).
12. Lumsden, N. G., Khambata, R. S. & Hobbs, A. J. C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target. Curr. Pharm. Des. 16, 4080-4088 (2010).
13. Inuzuka, M. et al. C-type natriuretic peptide as a new regulator of food intake and energy expenditure. Endocrinology. 151, 3633-3642 (2010).
14. Doi, K. et al. C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization. Arterioscler. Thromb. Vasc. Biol. 21, 930-936 (2001).
15. Itho, T. et al. C-type natriuretic peptide ameliorates monocrotaline-induced pulmonary hypertension in rats. Am. J. Respir. Crit. Care. Med. 170, 1204-1211 (2004).
16. Kimura, T. et al. C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice. Respir. Res. 19, 17:19 (2016).
17. Rubattu, S., Sciarretta, S., Valenti, V., Stanzione, R. & Volpe, M. Natriuretic peptides: an update on bioactivity, potential therapeutic use and implication in cardiovascular disease. Am. J. Hypertens. 21, 733-741 (2008).
18. Katafuchi, T., Garbers, D. L. & Albanesi, J. P. CNP/GC-B system: A new regulator of adipogenesis. Peptide. 31, 1906-1911 (2010).
19. Anghelina, M., Moldovan, L. & Moldovan, N. I. Preferential activity Tie2 promoter in arteriolar endothelium. J. Cell. Mol. Med. 9, 113-121 (2005).
20. Yasoda, A. et al. Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias. Endocrinology. 150, 3138-3144 (2009).
21. Berry, D. C., Stenesen, D., Zeve, D. & Graff, J. M. The developmental origins of adipose tissue. Development. 140, 3939-3949 (2013).
22. Harms, M. & Seale, P. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19, 1252-1263 (2013).
23. Vitali, A. et al. The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes. J. Lipid. Res. 53, 619-529 (2012).
24. Shen, W. et al. Acupuncture promotes white adipose tissue browning by inducing UCP1 expression on DIO mice. BMC. Complement. Altern. Med. 16, 501 (2014).
25. Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin. Invest. 117, 175-184 (2007).
26. Abdel-Misih, S. R. & Bloomston, M. Liver anatomy. Surg. Clin. North. Am. 90, 643-653 (2010).
27. Nguyen, P. et al. Liver lipid metabolism. J. Anim. Physiol. Anim. Nutr (Berl). 92, 272-283 (2008).
28. Libinaki, R. et al. Effects of genetic and diet-induced obesity on lipid metabolism. IUBMB. Life. 48, 109-113 (1999).
29. Leibel, R. L. Molecular physiology of weight regulation in mice and humans. Int. J. Obese (Lond). 32, S98-S108 (2008).
30. Barros, C. C. et al. Efficient method for obtaining Lep (ob)/Lep (ob)-derived animal models using adipose tissue transplantations. Int. J. Obese (Lond). 33, 938-944 (2009).
31. Zidek, L. M. et al. Deficiency in mTORC1-controlled C/EBPβ-mRNA translation improves metabolic health in mice. EMBO. Rep. 16, 1022-1036 (2015).
32. Despres, J. P. et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler. Thromb. Vasc. Biol. 28, 1039-1049 (2008).
33. Kanda, T. et al. PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice. J. Clin. Invest. 119, 110-124 (2009).
34. Reynes, B., Palou, M. & Palou, A. Gene expression modulation of lipid and central energetic metabolism related genes by high-fat diet intake in the main homeostatic tissues. Food. Funct. 8, 629-650 (2017).
35. Danforth, E. Jr. Failure of adipocyte differentiation causes type 2 diabetes mellitus? Nat. Genet. 26, 13 (2000).
36. Browning, J. D. & Horton, J. D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114, 147-152 (2004).
37. Marchesini, G. et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 50, 1844-1850 (2001).
38. Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184 (2007).
39. Villaret, A. et al. Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes. 59, 2755-2763 (2010).
40. Li, T. et al. Perivascular adipose tissue alleviates inflammatory factors and stenosis in diabetic blood vessels. Biochem. Biophys. Res. Commun. 480, 147-152 (2016).
41. Tanabe, S. & Grenier, D. Endothelial cell/macrophage cocultures as a model to study streptococcus suis-induced inflammatory responses. FEMS. Immunol. Med. Microbiol. 55, 100-106 (2009).
42. Wronkowitz, N., Romacho, T., Sell, H. & Eckel, J. Adipose tissue dysfunction and inflammation in cardiovascular disease. Front. Horm. Res. 43, 79-92 (2014).
43. Pober, J. S. & Sessa, W. C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7, 803-815 (2007).
44. Kawanishi, N., Yano, H., Yokogawa, Y. & Suzuki, K. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc. Immunol. Rev. 16, 105-118 (2010).
45. Kamei, N. et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 281, 26602-26614 (2006).
46. Schlueter, N. et al. Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome. Pharmacol. Ther. 144, 12-27 (2014).
47. Konrad, D. & Wueest, S. The gut-adipose-liver axis in the metabolic syndrome. Physiology (Bethesda). 29, 304-313 (2014).
48. Item, F. & Konrad, D. Visceral fat and metabolic inflammation: the portal theory revisited. Obes. Rev. 13, 30-39 (2012).
49. Sui, Y. et al. IKKβ links vascular inflammation to obesity and atherosclerosis. J. Exp. Med. 211, 869-886 (2014).
50. Ketonen, J., Shi, J., Martonen, E. & Mervaala, E. Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57BL/6 mice. Circ. J. 74, 1479-1487 (2010).
51. Szasz, T. & Webb, R. C. Perivascular adipose tissue: more than just structural support. Clin. Sci (Lond). 122, 1-12 (2012).
52. Wang, D. et al. Endothelial dysfunction and enhanced contractility in microvessels from ovariectomized rats: roles of oxidative stress and perivascular adipose tissue. Hypertension. 63, 1063-1069 (2014).
53. Brown, N. K. et al. Perivascular adipose tissue in vascular function and disease. Arterioscler. Thromb. Vasc. Biol. 34, 1621-1630 (2014).
54. Schlaeger, T. M., Qin, Y., Fugiwara, Y., Magram, J. & Sato, T. N. Vascular endothelial cell lineage-specific promoter in transgenic mice. Development. 121, 1089-1098 (1995).
55. Arbuthnott, E. Brown adipose tissue: structure and function. Proc. Nutr. Soc. 48, 177-182 (1989).
56. Gersh, I. & Still, M. A. Blood vessels in fat tissue. Relation to problems of gas exchange. J. Exp. Med. 81, 219-232 (1945).
57. Hirata, Y. et al. Hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension. Circulation. 78, 1401-1410 (1998).
58. Chusho, H. et al. Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways. Endocrinology. 141, 3807-3813 (2000).
59. Igaki, T. et al. Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide. Hypertens. Res. 21, 7-13 (1998).
60. Soeki, T. et al. C-Type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J. Am. Coll. Cardiol. 45, 608-616 (2005).
61. Kake, T. et al. Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice. Am. J. Physiol. Endocrinol. Metab. 297, E1339-1348 (2009).
62. Nakao, K. et al. Endothelium-Derived C-type natriuretic peptide contributes to blood pressure regulation by maintaining endothelial integrity. Hypertension. 69, 286-296 (2017).
63. Moyes, A. J. et al. Endothelial C-type natriuretic peptide maintains vascular homeostasis. J. Clin. Invest. 214, 4039-4051 (2014).
64. Rodbell, M. Metabolism of isolated fat cells. J. Biol. Chem. 239, 375-380 (1964).
65. Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917 (1959).